In patients with HR+/HER2- disease, we found a slightly increased risk in all-cause mortality and BC-related death for every 5-U increase in BMI (HR = 1.21, 95% CI 1.01–1.44 and HR = 1.58, 95% CI 1.11–1.72, respectively). Here, ERBB2 is linked to breast cancer.